BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12235148)

  • 21. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death.
    Amano M; Galvan M; He J; Baum LG
    J Biol Chem; 2003 Feb; 278(9):7469-75. PubMed ID: 12499376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic acute phase induction of murine beta-galactoside alpha 2,6 sialyltransferase (ST6Gal I) is IL-6 dependent and mediated by elevation of exon H-containing class of transcripts.
    Dalziel M; Lemaire S; Ewing J; Kobayashi L; Lau JT
    Glycobiology; 1999 Oct; 9(10):1003-8. PubMed ID: 10521536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups.
    Kitagawa H; Paulson JC
    J Biol Chem; 1994 Jan; 269(2):1394-401. PubMed ID: 8288606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular cloning, expression and properties of an alpha/beta-Galactoside alpha2,3-sialyltransferase from Vibrio sp. JT-FAJ-16.
    Takakura Y; Tsukamoto H; Yamamoto T
    J Biochem; 2007 Sep; 142(3):403-12. PubMed ID: 17673486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase.
    Appenheimer MM; Huang RY; Chandrasekaran EV; Dalziel M; Hu YP; Soloway PD; Wuensch SA; Matta KL; Lau JT
    Glycobiology; 2003 Aug; 13(8):591-600. PubMed ID: 12672700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biosynthesis of the cancer-related sialyl-alpha 2,6-lactosaminyl epitope in colon cancer cell lines expressing beta-galactoside alpha 2,6-sialyltransferase under a constitutive promoter.
    Dall'Olio F; Chiricolo M; Mariani E; Facchini A
    Eur J Biochem; 2001 Nov; 268(22):5876-84. PubMed ID: 11722575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sialylation of glycoprotein oligosaccharides N-linked to asparagine. Enzymatic characterization of a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase and a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase from rat liver.
    Weinstein J; de Souza-e-Silva U; Paulson JC
    J Biol Chem; 1982 Nov; 257(22):13845-53. PubMed ID: 7142180
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular cloning and expression of chick embryo Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase. Comparison with the mammalian enzyme.
    Kurosawa N; Kawasaki M; Hamamoto T; Nakaoka T; Lee YC; Arita M; Tsuji S
    Eur J Biochem; 1994 Jan; 219(1-2):375-81. PubMed ID: 8307003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine B cell differentiation is accompanied by programmed expression of multiple novel beta-galactoside alpha2, 6-sialyltransferase mRNA forms.
    Wuensch SA; Huang RY; Ewing J; Liang X; Lau JT
    Glycobiology; 2000 Jan; 10(1):67-75. PubMed ID: 10570225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine hepatic beta-galactoside alpha 2,6-sialyltransferase gene expression involves usage of a novel upstream exon region.
    Hu YP; Dalziel M; Lau JT
    Glycoconj J; 1997 Apr; 14(3):407-11. PubMed ID: 9147064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase and a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase to homogeneity from rat liver.
    Weinstein J; de Souza-e-Silva U; Paulson JC
    J Biol Chem; 1982 Nov; 257(22):13835-44. PubMed ID: 7142179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of beta-galactoside alpha 2,6-sialyltransferase does not alter the susceptibility of human colon cancer cells to NK-mediated cell lysis.
    Dall'Olio F; Mariani E; Tarozzi A; Meneghetti A; Chiricolo M; Lau JT; Facchini A
    Glycobiology; 1997 Jun; 7(4):507-13. PubMed ID: 9184831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human liver and human placenta both contain CMP-NeuAc:Gal beta 1-->4GlcNAc-R alpha 2-->3- as well as alpha 2-->6-sialyltransferase activity.
    Nemansky M; Schiphorst WE; Koeleman CA; Van den Eijnden DH
    FEBS Lett; 1992 Nov; 312(1):31-6. PubMed ID: 1426235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid, semi-automated method for detection of Galbeta1-4GlcNAc alpha2,6-sialyltransferase (EC 2.4.99.1) activity using the lectin Sambucus nigra agglutinin.
    Halliday JA; Franks AH; Ramsdale TE; Martin R; Palant E
    Glycobiology; 2001 Jul; 11(7):557-64. PubMed ID: 11447135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression.
    Kono M; Ohyama Y; Lee YC; Hamamoto T; Kojima N; Tsuji S
    Glycobiology; 1997 Jun; 7(4):469-79. PubMed ID: 9184827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-galactoside alpha2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with Sambucus nigra agglutinin.
    Dall'Olio F; Chiricolo M; Ceccarelli C; Minni F; Marrano D; Santini D
    Int J Cancer; 2000 Oct; 88(1):58-65. PubMed ID: 10962440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
    Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ
    Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethanol destabilizes liver Gal beta l, 4GlcNAc alpha2,6-sialyltransferase, mRNA by depleting a 3'-untranslated region-specific binding protein.
    Garige M; Gong M; Lakshman MR
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1076-82. PubMed ID: 16720754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymatic activity of a developmentally regulated member of the sialyltransferase family (STX): evidence for alpha 2,8-sialyltransferase activity toward N-linked oligosaccharides.
    Kojima N; Yoshida Y; Kurosawa N; Lee YC; Tsuji S
    FEBS Lett; 1995 Feb; 360(1):1-4. PubMed ID: 7875291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biosynthesis of mammalian glycoproteins. Glycosylation pathways in the synthesis of the nonreducing terminal sequences.
    Beyer TA; Rearick JI; Paulson JC; Prieels JP; Sadler JE; Hill RL
    J Biol Chem; 1979 Dec; 254(24):12531-4. PubMed ID: 500730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.